Overall, the OHTS has provided the ophthalmologist with more predictive diagnostic tools with which to evaluate ocular hypertension patients. An improved ability to identify those patients at ...
Summary. Clevidipine is a new lipophilic, short-acting, third-generation dihydropyridine calcium channel blocker (CCB) approved for use in the management of acute hypertension when oral agents are ...
SpyGlass Pharma announced completion of enrollment in its Phase I/II, randomized, multi-center, controlled clinical trial (NCT06120842) evaluating SpyGlass’ drug delivery platform in patients with ...
The ACR Appropriateness Criteria® (AC) are evidence-based guidelines to assist referring physicians and other providers in making the most appropriate imaging or treatment decision for a specific ...
He had a history of hypertension and dyslipidaemia and took amlodipine and rosuvastatin ... He lost consciousness and could not understand where he was or respond to instructions. His ocular ...